isoleucyl-prolyl-arginine-4-nitroanilide has been researched along with fibrin in 7 studies
| Studies (isoleucyl-prolyl-arginine-4-nitroanilide) | Trials (isoleucyl-prolyl-arginine-4-nitroanilide) | Recent Studies (post-2010) (isoleucyl-prolyl-arginine-4-nitroanilide) | Studies (fibrin) | Trials (fibrin) | Recent Studies (post-2010) (fibrin) |
|---|---|---|---|---|---|
| 23 | 0 | 0 | 15,994 | 328 | 3,808 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botstein, D; Brady, K; Johnson, AC; Kerr, EM; Nguyen, HV; Paoni, NF; Peña, LC; Refino, CJ; van Reis, R; Wurm, FM | 1 |
| Collen, D; Li, XK; Lijnen, HR; Nelles, L; Stassen, JM; Van Hoef, B | 1 |
| Castellino, FJ; deSerrano, VS; Urano, S; Urano, T | 1 |
| Fukao, H; Matsuo, O; Okada, K; Ueshima, S | 1 |
| Kakiki, M; Nagamatsu, A; Shimeno, H; Soeda, S | 1 |
| Chmielewska, J; Rånby, M; Wiman, B | 1 |
| Barstad, RM; Ezban, M; Hedner, U; Orning, L; Orvim, U; Petersen, LB; Sakariassen, KS | 1 |
7 other study(ies) available for isoleucyl-prolyl-arginine-4-nitroanilide and fibrin
| Article | Year |
|---|---|
Involvement of residues 296-299 in the enzymatic activity of tissue-type plasminogen activator.
Topics: Alanine; Amino Acid Sequence; Fibrin; Fibrinogen; Fibrinolysis; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligopeptides; Plasma; Plasminogen; Protein Engineering; Tissue Plasminogen Activator | 1992 |
Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1.
Topics: Amino Acid Sequence; Animals; Chemical Phenomena; Chemistry, Physical; Chromogenic Compounds; Cricetinae; DNA; Fibrin; Fibrinogen; Fibrinolysis; Gene Expression; Humans; Hydrolysis; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligopeptides; Plasminogen; Plasminogen Inactivators; Pulmonary Embolism; Recombinant Proteins; Tissue Plasminogen Activator | 1992 |
Stimulation by fibrinogen of the amidolytic activity of single-chain tissue plasminogen activator.
Topics: Amides; Dose-Response Relationship, Drug; Enzyme Activation; Fibrin; Fibrinogen; Kinetics; Oligopeptides; Recombinant Proteins; Tissue Plasminogen Activator | 1989 |
Monoclonal antibody enhances plasminogen activation by t-PA.
Topics: Antibodies, Monoclonal; Chromogenic Compounds; Fibrin; Fibrin Fibrinogen Degradation Products; Humans; Oligopeptides; Plasminogen; Protein Conformation; Tissue Plasminogen Activator | 1989 |
Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
Topics: Animals; Binding Sites; Chromatography, Affinity; Electrophoresis, Polyacrylamide Gel; Fibrin; Heparin; Oligopeptides; Plasminogen; Swine; Tissue Plasminogen Activator | 1987 |
Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.
Topics: Binding Sites; Fibrin; Fibrinogen; Glycoproteins; Humans; Isoflurophate; Kinetics; Ligands; Oligopeptides; Plasminogen Activators; Plasminogen Inactivators | 1988 |
Antithrombotic efficacy of inactivated active site recombinant factor VIIa is shear dependent in human blood.
Topics: Binding Sites; Blood Coagulation; Chromogenic Compounds; Dansyl Compounds; Factor VIIa; Fibrin; Fibrinolytic Agents; Hemorheology; Humans; Mutagenesis, Site-Directed; Oligopeptides; Phospholipids; Platelet Adhesiveness; Recombinant Fusion Proteins; Thromboplastin | 1997 |